A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease
GGL Biondi-Zoccai, M Lotrionte, P Agostoni… - European heart …, 2006 - academic.oup.com
Aims The role of aspirin in patients with coronary artery disease (CAD) is well established,
yet patients happen to discontinue aspirin according to physician's advice or unsupervised …
yet patients happen to discontinue aspirin according to physician's advice or unsupervised …
Review and meta-analysis of incidence and clinical predictors of anthracycline cardiotoxicity
M Lotrionte, G Biondi-Zoccai, A Abbate… - The American journal of …, 2013 - Elsevier
The management of individual patients requiring anthracyclines remains challenging
because uncertainty persists on predictors of cardiotoxicity. We aimed to perform a …
because uncertainty persists on predictors of cardiotoxicity. We aimed to perform a …
A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery …
BACKGROUND: Cardiac surgery is the standard treatment for unprotected left main disease
(ULM). Drug-eluting stent (DES) implantation has been recently reported in patients with …
(ULM). Drug-eluting stent (DES) implantation has been recently reported in patients with …
Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes
G Biondi-Zoccai, M Lotrionte, P Agostoni… - International journal of …, 2011 - Elsevier
BACKGROUND: Clopidogrel is beneficial after ACS. Recent data suggest the superiority of
prasugrel or ticagrelor compared with clopidogrel. However, there is no comparison of …
prasugrel or ticagrelor compared with clopidogrel. However, there is no comparison of …
International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences
M Lotrionte, G Biondi-Zoccai, M Imazio, D Castagno… - American heart …, 2010 - Elsevier
BACKGROUND: Acute pericarditis is common, yet uncertainty persists on its treatment. We
thus aimed to conduct a comprehensive systematic review on pharmacologic treatments for …
thus aimed to conduct a comprehensive systematic review on pharmacologic treatments for …
[HTML][HTML] The rough guide to systematic reviews and meta-analyses
G Biondi-Zoccai, M Lotrionte, G Landoni… - HSR proceedings in …, 2011 - ncbi.nlm.nih.gov
The hierarchy of evidence based medicine postulates that systematic reviews of
homogenous randomized trials represent one of the uppermost levels of clinical evidence …
homogenous randomized trials represent one of the uppermost levels of clinical evidence …
Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients
…, G Sangiorgi, M Lotrionte… - Journal of …, 2009 - journals.sagepub.com
Purpose: To report a systematic review of the literature published on the outcomes of
stenting for below-the-knee disease in patients with critical limb ischemia (CLI). Methods …
stenting for below-the-knee disease in patients with critical limb ischemia (CLI). Methods …
Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy …
Objective To appraise multiple systematic reviews on the same clinical topic, focusing on
predictors and correlates of quality of reporting of meta-analysis (QUOROM) scores. Design …
predictors and correlates of quality of reporting of meta-analysis (QUOROM) scores. Design …
Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)
…, G Villata, M Bollati, D Sillano, M Lotrionte… - Vascular health and …, 2008 - Taylor & Francis
Percutaneous coronary revascularization has been a mainstay in the management of
coronary artery disease since its introduction in the late 1970s. Bare-metal stents and, more …
coronary artery disease since its introduction in the late 1970s. Bare-metal stents and, more …
Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention
GGL Biondi-Zoccai, M Lotrionte, M Anselmino… - American heart …, 2008 - Elsevier
BACKGROUND: Drug-eluting stents reduce the risk of restenosis after percutaneous
coronary intervention (PCI) but may pose a risk of thrombosis. Cilostazol, an oral antiplatelet …
coronary intervention (PCI) but may pose a risk of thrombosis. Cilostazol, an oral antiplatelet …